Charles River Laboratories International, Inc. (NYSE:CRL) Q3 2024 Earnings Call Transcript
Charles River Laboratories International, Inc. (NYSE:CRL) Q3 2024 Earnings Call Transcript November 6, 2024Charles River Laboratories International, Inc.
Posts Tagged ‘NYSE:CRL’
Higher Interest Environment Negatively Impacted Charles River Laboratories (CRL)
Brown Capital Management, an investment management company, released its “The Brown Capital Management Mid Company Fund” second quarter 2024 investor letter.
Charles River Laboratories International (CRL) Fell Due to a More Cautious Funding Environment
Ariel Investments, an investment management company, released its “Ariel Appreciation Fund” second-quarter 2024 investor letter.
Charles River Laboratories International, Inc. (NYSE:CRL) Q2 2024 Earnings Call Transcript
Charles River Laboratories International, Inc. (NYSE:CRL) Q2 2024 Earnings Call Transcript August 7, 2024Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc. (NYSE:CRL) Q1 2024 Earnings Call Transcript
Charles River Laboratories International, Inc. misses on earnings expectations. Reported EPS is $1.44 EPS, expectations were $2.05.
Charles River Laboratories International, Inc. (NYSE:CRL) Q4 2023 Earnings Call Transcript
Charles River Laboratories International, Inc. beats earnings expectations. Reported EPS is $2.46, expectations were $2.39. Charles River Laboratories International, Inc.
10 Narrow Moat Stocks Hedge Funds Are Buying
In this article, we discuss the 10 narrow moat stocks hedge funds are buying.
Charles River Laboratories International, Inc. (NYSE:CRL) Q3 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Charles River Laboratories' Third Quarter 2023 Earnings Conference Call.
Long-Term Returns of Billionaire Barry Rosenstein’s Activist Targets
In this article, we discuss the long-term returns of Rosenstein's Jana Partners' activist targets.
Charles River Laboratories International, Inc. (NYSE:CRL) Q2 2023 Earnings Call Transcript
Operator: Please stand by your program is about to begin.
Charles River Laboratories International, Inc. (NYSE:CRL) Q1 2023 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Charles River Laboratories First Quarter 2023 Earnings Conference Call.
Charles River Laboratories International, Inc. (NYSE:CRL) Q4 2022 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Charles River Laboratories Fourth Quarter and Full Year 2022 Earnings Conference Call.
Should You Invest in Charles River Laboratories International (CRL) for the Long-Term?
Jackson Square Partners, an investment management firm, released its “SMID-Cap Growth” Q3 2022 investor letter. A copy of the same can be downloaded here.
16 Large-Cap Stocks with Insider Buying
In this article, we will discuss the 16 large-cap stocks with insider buying.
Here’s What Makes Charles River Laboratories International (CRL) a High Potential Long-Term Investment
Polen Capital, an investment management company, released its “Polen U.S. SMID Company Growth” second quarter 2022 investor letter.
Why These 5 Stocks Are Trending Today
Eli Lilly and Company (NYSE:LLY) is trending today after Jasper Hellweg of Argus raised his price target on the stock to $360 from $315.
10 Stocks to Buy in 2022 According to John Rogers’ Ariel Investments
In this article, we discuss 10 Stocks to Buy in 2022 According to John Rogers' Ariel Investments.
10 Biggest Losers in Gabriel Plotkin’s Melvin Capital Portfolio
In this article, we discuss the 10 biggest losers in Gabriel Plotkin's Melvin Capital portfolio.
Here’s Why You Should Buy Charles River Laboratories (CRL) Shares
ClearBridge Investments, an investment management firm, published its “All Cap Growth Strategy” fourth quarter 2021 investor letter – a copy of which can be downloaded here...
Were Hedge Funds Illusioned With Charles River Laboratories International Inc. (CRL)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Is Charles River Laboratories (CRL) A Worthy Stock Investment?
ClearBridge Investments, an investment management firm, published its “SMID Cap Growth Strategy” third quarter 2021 investor letter – a copy of which can be downloaded here...
Hedge Funds Are Piling Into Charles River Laboratories International Inc. (CRL)
In this article we will check out the progression of hedge fund sentiment towards Charles River Laboratories International Inc.
10 Best Healthcare Stocks to Buy According to Greg Martinez’s Parkman Healthcare Partners
In this article, we discuss the 10 best healthcare stocks to buy according to Greg Martinez's Parkman Healthcare Partners.
5 Healthcare Stocks to Buy According to John Rogers’ Ariel Investments
In this article, we discuss the 5 healthcare stocks to buy according to John Rogers’ Ariel Investments.
Hedge Funds Keep Buying Charles River Laboratories International Inc. (CRL)
A whopping number of 13F filings filed with U.S.
Here’s What Makes Charles River Laboratories (CRL) A Great Investment
ClearBridge Investments, an investment management firm, published its “Mid Cap Growth Strategy” second quarter 2021 investor letter – a copy of which can be downloaded ...
Here is What Hedge Funds Think About Charles River Laboratories International Inc. (CRL)
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending, many smart money investors...
Is CRL Stock A Buy or Sell?
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending, many smart money investors...
Hedge Fund and Insider Trading News: Crispin Odey, Bill Ackman, Point72 Asset Management, Elliott Management, Charles River Laboratories International Inc (CRL), Corvus Gold Inc (KOR), and More
Crispin Odey’s long decline is exposing a new risk for the investors who are left: as his troubled money pool gets smaller, a larger slice is in hard-to-sell holdings.
Ariel Investments, Still Hopeful for Charles River Lab (CRL) to Continue Positive Momentum
Ariel Investments, a minority-owned investment company that focuses in small and mid-capitalized US based stocks, published its third-quarter 2020 Investor Letter – a copy of...
Is CRL A Good Stock To Buy Now?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great...
Is Charles River Laboratories (CRL) a Smart Long-term Buy?
Brown Capital Management Mid Company Fund recently released its Q3 2020 Investor Letter, a copy of which you can download here. The fund posted a return of 6.15% (inst.
Were Hedge Funds Right About Crowding Into Charles River Laboratories (CRL)?
Is Charles River Laboratories International Inc.
Hedge Funds Have Never Been This Bullish On Charles River Laboratories (CRL)
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file ...
Should Investors Buy the Dip in Charles River Laboratories (CRL) Stock?
Brown Advisory recently released its Q2 2020 Investor Letter, a copy of which you can download here.
Did Hedge Funds Make The Right Call On Charles River Laboratories International Inc. (CRL) ?
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file ...
Hedge Funds Never Been This Bullish On Charles River Laboratories International (CRL)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Why Horizon Kinetics is Bullish on Charles River Laboratories (CRL) Stock?
Horizon Kinetics LLC, a New York-based investment advisory firm founded in 1994, released its Q1 2020 Commentary – a copy of which is available for download here.
Is Charles River Laboratories International Inc. (CRL) Relatively A Good Stock To Buy?
We hate to say this but, we told you so.
How Did Charles River Laboratories International Inc. (CRL) Compare Against Top Hedge Fund Stocks in 2019?
It has been a fantastic year for equity investors as Donald Trump pressured Federal Reserve to reduce interest rates and finalized the first leg of a trade deal with China.
Hedge Funds Have Never Been This Bullish On Charles River Laboratories International Inc. (CRL)
The 700+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity...
Is Charles River Laboratories International Inc. (CRL) Going To Burn These Hedge Funds ??
Concerns over rising interest rates and expected further rate increases have hit several stocks hard during the fourth quarter of 2018.
Is Charles River Laboratories International Inc. (CRL) A Good Stock To Buy?
Does Charles River Laboratories International Inc.
Were Hedge Funds Right About Piling Into Charles River Laboratories International (CRL)?
Hedge funds are known to underperform the bull markets but that's not because they are terrible at stock picking.
Charles River Laboratories International Inc. (CRL): Are Hedge Funds Right About This Stock?
The fourth quarter was a rough one for most investors, as fears of a rising interest rate environment in the U.S, a trade war with China, and a more or less stagnant Europe, weighed...
Hedge Fund and Insider Trading News: Kora Management, Glendon Capital, Armistice Capital, Hill International Inc (HIL), Athenex Inc (ATNX), and More
Jared Kushner, US President Donald Trump’s son-in-law, arrived in Jaisalmer on Friday, 23 November to attend his friend Nitin Saigal’s wedding.
Hedge Fund and Insider Trading News: Tiger Global, Elliott Management, Walgreens Boots Alliance Inc (WBA), Oracle Co. (ORCL), and More
The Viral Fever (TVF), an over-the-top (OTT) platform which creates original video content, has raised an additional $6 million (around Rs 41 crore at current exchange rates) ...
Is Charles River Laboratories Intl. Inc (CRL) A Good Stock for Your Portfolio?
You probably know from experience that there is not as much information on small-cap companies as there is on large companies.
Here is What Hedge Funds Think About Charles River Laboratories (CRL)
Is Charles River Laboratories (NYSE:CRL) a good stock to buy right now? We at Insider Monkey like to examine what billionaires and hedge funds think of a company before doing ...
The Best Healthcare Stock Ideas Of HealthInvest Partners AB
Anders Hallberg and Carl Bennet's HealthInvest Partners AB is one of the hundreds of elite funds tracked by Insider Monkey which has filed a list of its equity holdings with the...
